Cited by 75Gut microbiota and healthLiver Disease Diagnosis and TreatmentGastrointestinal motility and disorders

Impact of hypocaloric hyperproteic diet on gut microbiota in overweight or obese patients with nonalcoholic fatty liver disease: a pilot study

Open access
Pataky, Zoltan, Genton, Laurence, Spahr, Laurent, Lazarevic, Vladimir, Terraz, Sylvain, Gaïa, Nadia, Rubbia-Brandt, Laura, Golay, Alain +2 more·2016·Digestive Diseases and Sciences

Abstract

Background NAFLD is likely to become the most common cause of chronic liver disease. The first-line treatment includes weight loss.Aims To analyze the impact of a hypocaloric hyperproteic diet (HHD) on gut microbiota in NAFLD patients.Methods Fifteen overweight/obese patients with NAFLD were included. At baseline and after a 3-week HHD (Eurodiets(®), ~1000 kcal/day, ~125 g protein/day), we measured gut microbiota composition and function by shotgun metagenomics; body weight; body composition by bioelectrical impedance analysis; liver and visceral fat by magnetic resonance imaging; plasma C-reactive protein (CRP); and liver tests. Results between both time points, expressed as median (first and third quartile), were compared by Wilcoxon signed-rank tests.Results At baseline, age was 50 (47-55) years and body mass index 34.6 (32.4, 36.7) kg/m(2). HDD decreased body weight by 3.6 % (p < 0.001), percent liver fat by 65 % (p < 0.001), and CRP by 19 % (p = 0.014). HDD was associated with a decrease in Lachnospira (p = 0.019), an increase in Blautia (p = 0.026), Butyricicoccus (p = 0.024), and changes in several operational taxonomic units (OTUs) of Bacteroidales and Clostridiales. The reduced liver fat was negatively correlated with bacteria belonging to the Firmicutes and Bacteroidetes phyla (a Ruminococcaceae OTU, r = -0.83; Bacteroides, r = -0.73). The associated metabolic changes concerned mostly enzymes involved in amino acid and carbohydrate metabolism.Conclusions In this pilot study, HHD changes gut microbiota composition and function in overweight/obese NAFLD patients, in parallel with decreased body weight, liver fat, and systemic inflammation. Future studies should aim to confirm these bacterial changes and understand their mode of action.Trail registration Under clinicaltrials.gov: NCT01477307.

Integrity signals

Registry

Crossref · 10.1007/s10620-016-4179-1

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pataky, Z., Genton, L., Spahr, L., Lazarevic, V., Terraz, S., Gaïa, N., Rubbia-Brandt, L., Golay, A., Schrenzel, J., & Pichard, C.
Affiliations
University of Geneva (CH)
Corresponding author
Pataky, Zoltan
Venue
Digestive Diseases and Sciences
Published
2016-05-03
Volume
61
Issue
9
Pages
2721-2731
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W2346281792
Cited by
75
References
49
Citations by year
2026: 5 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 9 · 2018: 6 · 2017: 5
FWCI
3.46
Type
journal article
Language
en
Open access
Locations
  • Digestive Diseases and Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • Eurodiet
  • Flags Foundation
  • Research Fund of the Department of Internal Medicine of the University Hospital
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
non-alcoholic fatty liver disease, gut microbiota, weight loss, obesity, overweight, liver fat, systemic inflammation, C-reactive protein, Lachnospira, Blautia, Butyricicoccus, Firmicutes, Bacteroidetes, Ruminococcaceae, Bacteroides, amino acid metabolism, carbohydrate metabolism
MeSH terms
Eubacteriales, Gastrointestinal Microbiome, Adipose Tissue, Alanine Transaminase, Aspartate Aminotransferases, Bacteroides, Blood Glucose, Body Composition, C-Reactive Protein, Cholesterol, Classification, Dietary Proteins, DNA, Bacterial, Female, gamma-Glutamyltransferase, Humans, Cholesterol, HDL, Cholesterol, LDL, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Obesity, Pilot Projects, Prospective Studies, Triglycerides, Cohort Studies, Electric Impedance, Sequence Analysis, DNA, Caloric Restriction, Intra-Abdominal Fat, Overweight, Metagenomics, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review